PERRY DAVID P 4
4 · Better Therapeutics, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
PERRY DAVID P
DirectorSee Remarks10% Owner
Transactions
- Purchase
Common Stock
2022-09-15$1.99/sh+10,844$21,623→ 62,380 total - Purchase
Common Stock
2022-09-16$2.07/sh+39,156$80,975→ 101,536 total
Holdings
- 21,336(indirect: By Trust)
Common Stock
- 10,464,015(indirect: By Trust)
Common Stock
- 293,150(indirect: By Spouse)
Common Stock
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.92 to $2.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.99 to $2.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Reflects the correction of an immaterial error in Column 5 reported in the Reporting Person's Form 4 filed on November 1, 2021.
- [F4]These shares are owned directly by Mr. Perry's spouse, Georgianna Maule-Ffinch.
- [F5]These shares are owned directly by Donald R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Georgianna Maule-Ffinch.
- [F6]These shares are owned directly by the David P. Perry 2015 Trust (the "Perry Trust"), a ten percent owner of Issuer, and indirectly by Mr. Perry as trustee of the Perry Trust. Mr. Perry is an officer, director and ten percent owner of the Issuer.